Hypermarcas (OTCMKTS:HYPMY) Sees Strong Trading Volume – Still a Buy?

Hypermarcas (OTCMKTS:HYPMY) saw strong trading volume on Friday . 118,047 shares were traded during mid-day trading, an increase of 361% from the previous session’s volume of 25,629 shares.The stock last traded at $4.12 and had previously closed at $4.04.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy”.

Hypermarcas Price Performance

The stock has a market cap of $2.90 billion, a P/E ratio of 8.58 and a beta of 0.70. The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61. The firm’s fifty day moving average price is $4.51 and its 200-day moving average price is $4.47.

Hypermarcas (OTCMKTS:HYPMY) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $383.13 million during the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%. Analysts forecast that Hypermarcas will post 0.53 earnings per share for the current year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.